Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Dec 11, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, providing a sustained and effective solution for managing intraocular pressure (IOP). Differing from traditional eye drops that need to be applied every day, iDose® TR is a small, implantable device engineered to release a controlled medication delivery directly into the eye over an extended period. This cutting-edge approach removes the hassle of daily applications, significantly improving patient adherence and overall treatment outcomes.

At Eye Center South, we are honored to introduce iDose® TR as part of our all-encompassing glaucoma care. The device is implanted during a simple and low-risk procedure, ensuring patient comfort and convenience. Once in place, it ensures a steady release of glaucoma medication, keeping IOP levels consistent and safeguarding your eyesight. Patients who find challenges in the demands of frequent eye drop use can experience significant advantages from this cutting-edge treatment.



Visit for more info At Eye Center South